Moderna and Aldevron announced that they have expanded their collaboration in support Moderna’s COVID-19 vaccine program and additional programs. Under the expanded agreement, Aldevron will supply plasmid DNA to serve as the genetic template for generating the COVID-19 mRNA vaccine. Buildout and validation of an additional 189,000 -ft2 expansion to the GMP facility on Aldevron’s campus has been completed, enabling additional manufacturing capacity. Source: Biopharm International 27/5/21